Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|June 28, 2024
Carfilzomib, lenalidomide, dexamethasone (KRD) in BTKi relapsed or refractory mantle cell lymphoma: A phase II study from Fondazione Italiana LinfomiFederica Cavallo, Michele Clerico, Elisa Lucchini, et al.
Pathology, Research and Practice|December 21, 2024
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplantRaffaella Guazzo, Anja Fischer, Margherita Vannucchi, et al.
Human Pathology|April 17, 2009
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesisStefano Lazzi, Cristiana Bellan, Anna Onnis, et al.
American Journal of Blood Research|September 20, 2021
Ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a real-life, retrospective, multicenter trial on behalf of the "RTL" (regional Tuscan lymphoma network)Emanuele Cencini, Bianca Mecacci, Francesca Morelli, et al.
Leukemia & Lymphoma|September 23, 2014
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practicePier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, et al.
Cancers|November 9, 2024
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous LymphomasMartina D'Onghia, Maria Mendonça-Sanches, Maria Erasti, et al.
Annals of Hematology|February 3, 2023
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network)Emanuele Cencini, Ilaria Romano, Francesco Ghio, et al.
Hematological Oncology|August 8, 2015
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessmentEmanuele Cencini, Alberto Fabbri, Luigi Rigacci, et al.
Hematological Oncology|October 31, 2012
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective studyPier Luigi Zinzani, Cinzia Pellegrini, Emanuela Merla, et al.
Leukemia & Lymphoma|August 12, 2014
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)Alessandra Tucci, Maurizio Martelli, Luigi Rigacci, et al.
Pageof 9